Tidal Trust III Intech S&P Large Cap Diversified Alpha ETF (ARCA: LGDX)

Ultime notizie per Tidal Trust III Intech S&P Large Cap Diversified Alpha ETF (ARCA:LGDX)

Technology

Consumer Cyclical

Financial Services

Healthcare

Industrials

Consumer Defensive

Communication Services

Energy

Real Estate

Utilities

Basic Materials

Other

To seek to achieve its investment objective, the Funds sub-adviser, Intech Investment Management LLC (the Sub-Adviser or Intech), primarily invests the Funds assets in common stocks of companies included in the S&P 500 Index (the Index). Intech uses a quantitative process to construct a portfolio that seeks to outperform the Index (i.e., produce alpha) by improving diversification relative to the Index seeking more balanced contributions of risk and return and systematically rebalancing the portfolio.

Nvidia Corp.United States -Information Technology

Apple Inc.

Meta Platforms, Inc.

AMAZON.COM INC

Microsoft Corporation

Tesla Inc Consumer Discretionary

Wells Fargo And Company $44

Netflix Inc

Eli Lilly And Company

Broadcom Inc

Intech S&P Large Cap Diversified Alpha ETF

Large Cap

News

New ETFs

Small Cap

ETFs

LGDX

SMDX

Arrivano soluzioni per investire in sicurezza: diversificazione e strategie innovative per proteggere i tuoi risparmi.

Mercati volatili? Intech lancia due nuovi ETF per dormire sonni tranquilli

Tidal Trust III Intech S&P Large Cap Diversified Alpha ETF

WIIM

KRMD

KORU Medical Systems shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY25 sales guidance above estimates.

Goldman Sachs analyst Jamie Perse maintains Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) with a Neutral and raises the price target from $2.5 to $5.

Price Target

Analyst Ratings

Goldman Sachs Maintains Neutral on Agilon Health, Raises Price Target to $5

F&G Annuities & Life shares are trading lower after the company reported Q1 financial results and missed its adjusted EPS and revenue estimates.

ACAD

ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q1 financial results.

BLZE

Backblaze shares are trading higher after the company reported better-than-expected Q1 financial results.

RVMD

Revolution Medicines shares are trading higher after Oppenheimer raised its price target on the stock from $70 to $75.

Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) has outperformed the market over the past 5 years by 8.03% on an annualized basis producing an average annual return of 22.54%. Currently, Corteva has a market capitalization of $43.88 billion. 
Buying $100 In CTVA: If an investor had bought $100 of CTVA stock 5 years ago, it would be worth $263.49 today based on a price of $64.24 for CTVA at the time of writing.
<h3>Corteva's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746715545_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CTVA

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Openlane shares are trading higher after the company reported better-than-expected Q1 financial results.

Oppenheimer analyst Ian Zaffino maintains Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) with a Outperform and raises the price target from $65 to $85.

Oppenheimer Maintains Outperform on Turning Point Brands, Raises Price Target to $85

INGN

Inogen shares are trading lower after the company reported Q1 financial results and issued Q2 sales guidance below estimates. Also, Stifel maintained a Hold rating on the stock and lowered its price target from $10 to $7.

First Advantage shares are trading higher after the company reported better-than-expected Q1 financial results.

WGRX

WGRX stock has given up its prior gain. Wellgistics Health shares were trading higher after the company secured a $50 million equity line of credit facility.

Scotiabank analyst Robert Hope maintains TransAlta (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) with a Sector Perform and lowers the price target from C$17 to C$16.

TSX:TA

Scotiabank Maintains Sector Perform on TransAlta, Lowers Price Target to C$16

ADMA

ADMA Biologics shares are trading lower after the company reported worse-than-expected Q1 financial results.

Stephens &amp; Co. analyst Pooran Sharma maintains Bunge Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) with a Overweight and lowers the price target from $90 to $85.

Stephens & Co. Maintains Overweight on Bunge Global, Lowers Price Target to $85

Applovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) shares are trading higher Thursday after the company reported better-than-expected <a href="https://www.benzinga.com//node/45269045">first-quarter earnings</a> on Wednesday.
What To Know: The company reported adjusted earnings per share of $1.67, beating the consensus estimate of $1.45. In addition, the company reported sales of $1.48 billion, beating the consensus estimate of $1.38 billion and representing a 40% year-over-year increase.
The company broke down revenue further, reporting $1.15 billion in Advertising revenue and $325 million in Apps revenue. Advertising revenue increased 71% year-over-year and Apps revenue declined 14%.
Outlook: The company guided second-quarter advertising revenue from $1.19 billion to $1.21 billion.
See Also: <a href="https://www.benzinga.com/news/25/05/45281537/gop-warns-trump-appointed-social-security-chief-frank-bisignano-against-further-staff-cuts-citing-risks-to-services-as-baby-boomers-age">GOP Warns Trump-Appointed Social Security Chief Frank Bisignano Against Further Staff Cuts, Citing Risks To Services As Baby Boomers Age</a>
APP Price Action: At the time of publication, Applovin stock is trading 12.9% higher at $342.74, per data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro.</a>
Image: via Shutterstock

Movers

Applovin Stock Is Rising Thursday: What's Going On?

Mistras Group shares are trading lower after the company reported worse-than-expected Q1 financial results.

Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) will release earnings results for the first quarter, after the closing <a href="https://www.benzinga.com/quote/coin/earnings">bell on Thursday, May 8.</a>
Analysts expect the New York-based company to report quarterly earnings at $2.11 per share. Coinbase projects to report quarterly revenue at $2.12 billion, compared to $1.64 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company beat analyst estimates for revenue in the last reported quarter, while beating estimates in eight of the last 10 quarters overall.
Coinbase shares fell 0.2% to close at $196.56 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/COIN/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Peter Christiansen maintained a Buy rating and cut the price target from $350 to $270 on May 2, 2025. This analyst has an accuracy rate of 63%.</li>
<li>JP Morgan analyst Kenneth Worthington maintained a Neutral rating and slashed the price target from $344 to $276 on May 2, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Benchmark analyst Mark Palmer initiated coverage on the stock with a Buy rating and a price target of $252 on April 23, 2025. This analyst has an accuracy rate of 79%.</li>
<li>JMP Securities analyst Devin Ryan maintained a Market Outperform rating and slashed the price target from $475 to $400 on April 8, 2025. This analyst has an accuracy rate of 82%.</li>
<li>Barclays analyst Benjamin Budish maintained an Equal-Weight rating and cut the price target from $328 to $169 on April 7, 2025. This analyst has an accuracy rate of 80%.</li>
</ul>
Considering buying COIN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08025703/image-78-1024x529.png" alt="" class="wp-image-907194" style="width:584px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08025703/image-78-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08025703/image-78-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08025703/image-78-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08025703/image-78.png 1201w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45250672/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

COIN

Coinbase Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Chardan Capital analyst Rudy Li initiated coverage on Centessa Pharmaceuticals plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>) with a Buy rating and announced a price target of $30. Centessa Pharmaceuticals shares closed at $12.11 on Wednesday. <a href="https://www.benzinga.com/quote/CNTA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer analyst Andreas Argyrides initiated coverage on InflaRx N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFRX#NASDAQ">IFRX</a>) with an Outperform rating and announced a price target of $6. InflaRx shares closed at $1.49 on Wednesday. <a href="https://www.benzinga.com/quote/IFRX/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying CNTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08104113/image-91-1024x586.png" alt="" class="wp-image-908242" style="width:665px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08104113/image-91-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08104113/image-91-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08104113/image-91-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08104113/image-91.png 1137w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45284390/how-to-earn-500-a-month-from-mckesson-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings</a> </li>
</ul>
Photo via Shutterstock

Initiation

CNTA

IFRX

This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

Smart contracts have long been the backbone of blockchain&#8217;s promise. These self-executing programs run exactly as coded, without downtime, fraud, or third-party interference—at least in theory. But in 2025, with billions flowing through decentralized protocols and institutional players dipping into Web3, a bigger question looms: Are smart contracts finally ready for prime time?
For investors, understanding where smart contracts succeed, where they still stumble, and how they are evolving is critical to making informed bets on the future of finance.
<h3 class="wp-block-heading">What Are Smart Contracts (Really)?</h3>
At their core, smart contracts are pieces of code that automatically execute transactions once predefined conditions are met. Think of them as programmable agreements that don't require lawyers, banks, or platforms to verify or enforce.
They power everything from decentralized exchanges and lending protocols to NFT marketplaces and automated insurance payouts. Ethereum popularized them, but now they exist across multiple chains (e.g., Solana, Avalanche, Cardano, Polkadot, and layer-2s like Arbitrum).
<h3 class="wp-block-heading">The Promise: Efficiency, Transparency, Autonomy</h3>
For investors and builders alike, smart contracts offer powerful advantages:
<ul>
<li>Lower overhead: No intermediaries or administrative costs</li>
<li>Global access: Anyone with internet and a crypto wallet can interact</li>
<li>Immutable records: Transactions are transparent and tamper-proof</li>
<li>Programmable finance: Logic-based flows for lending, staking, governance, and more</li>
</ul>
In a world where speed and trust matter, smart contracts promise both.
<h3 class="wp-block-heading">The Challenges: Risk, Complexity, and Regulation</h3>
Despite the promise, smart contracts are not bulletproof. In fact, their biggest strength—autonomy—is also a major risk.
<ul>
<li>Code is law: If there's a bug, there's no undo button. The infamous 2016 DAO hack cost $60 million due to a coding vulnerability.</li>
<li>Security gaps: Even well-audited contracts can be exploited, and small errors can lead to major losses.</li>
<li>Scalability: Some chains still struggle with throughput and high fees during network congestion.</li>
<li>Legal uncertainty: Many jurisdictions don't yet recognize smart contracts as enforceable agreements.</li>
</ul>
For institutional adoption to scale, these issues must be addressed.
<h3 class="wp-block-heading">The Maturity Shift: Where Smart Contracts Are Winning</h3>
In 2025, smart contracts will have matured significantly in several verticals:
<ul>
<li>DeFi: Protocols like Aave, Uniswap, and Compound process billions in volume, governed entirely by smart contracts.</li>
<li>Insurance: Crop and travel insurance payouts triggered by oracles and automated triggers are gaining traction.</li>
<li>Real Estate and Tokenization: Smart contracts are being used for fractionalized ownership, rent distribution, and compliance automation.</li>
<li>DAOs: Decentralized governance mechanisms are using smart contracts for voting, treasury management, and incentive distribution.</li>
</ul>
These are no longer experiments. They&#8217;re operational.
<h3 class="wp-block-heading">What Investors Should Be Watching</h3>
<ul>
<li>Auditing and security firms: As smart contracts scale, so does the demand for verification and protection.</li>
<li>Layer-2 solutions and scalability tech: These make smart contracts faster and cheaper to use.</li>
<li>Cross-chain operability: Projects solving fragmentation will unlock broader use cases.</li>
<li>Legal-tech hybrids: Firms merging smart contract logic with enforceable legal frameworks could bridge the regulatory gap.</li>
</ul>
<h3 class="wp-block-heading">Final Thought: The Contract of the Future Is Already Here</h3>
Smart contracts aren't perfect. But in 2025, they're no longer an experiment. They are an active infrastructure for billions in financial activity.
Investors who understand their power—and their limitations—will be better positioned as finance continues its shift toward automation, transparency, and global accessibility.
So are smart contracts ready for prime time?
In many places, they already are. And the next wave is only getting started.

Comments

Tidal Trust III Intech S&P Large Cap Diversified Alpha ETF

Notizie

Ultime notizie per Tidal Trust III Intech S&P Large Cap Diversified Alpha ETF (ARCA:LGDX)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO